MAP 2017 – Molecular Analysis for Personalised Therapy

ESMO 2018 Congress

Preceptorship Courses

Apply now to join one of our Preceptorship courses on Immuno-oncology, Lung Cancer and Ovarian Cancer

Workshops & Courses

ESMO fosters the advancement of cancer research by supporting clinical trials workshops to inspire young oncologists from different disciplines across the globe to become the next generation of active researchers.

Patient Guides

Guides for Patients are designed to assist patients, their relatives and caregivers to better understand the nature of different types of cancer and evaluate the best available treatment choices

Personalised Medicine Explained

Video interviews and articles designed to help patients, policy makers and other non-medical professionals better understand the principles of personalised cancer medicine

Getting the Most out of Your Oncologist

Now available in Romanian, our Guide for Patients with Advanced Cancer is designed for patients, their family members and oncologists.

Designated Centres of Integrated Oncology and Palliative Care

The ESMO Designated Centres of Integrated Oncology and Palliative Care accreditation programme recognises cancer centres which provide comprehensive services in supportive and palliative care as part of their routine care.

EFPIA Disclosure Code

ESMO Workshops & Courses

ESMO fosters the advancement of cancer research by supporting clinical trials workshops to inspire young oncologists from different disciplines across the globe to become the next generation of active researchers.

The discovery of new and innovative genetic tests, targeted therapies and innovative treatment strategies can be enhanced through specific training of junior researchers in the design and methodology of clinical trials protocols. Particularly interesting are those trials with a strong translational research component that further advances the understanding of cancer as a disease.

Carefully designed clinical trials allow the prioritisation of resources and funding. They also facilitate the selection and prospective development of clinico-genomic and ‘niche’ clinical trials, necessary to increase the success and discovery of answers to strategically important clinical questions.

In the practice of medical oncology, the application of the principles of good clinical and laboratory practice is essential to achieve effective and measurable results that can be translated into evidence-based medicine and can directly contribute to new standards of patient care.